Wollenhaupt J, Silverfield J, Lee B, et al. Tofacitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in open-label, long-term extension studies over 8 years. EULAR 2017, THU0197.
Ziekteactiviteit beoordelen met DAPSA op basis van 28 gewrichten
dec 2018 | Arthritis psoriatica